Bone Regeneration — Teriparatide on Maxillary Sinus Floor Osseointegration
Citation(s)
Aggarwal P, Zavras A Parathyroid hormone and its effects on dental tissues. Oral Dis. 2012 Jan;18(1):48-54. doi: 10.1111/j.1601-0825.2011.01850.x. Epub 2011 Sep 6.
Ali MN, Kobayashi T, Tanaka M, Ohshima H, Ejiri S, Saito C Effects of intermittent parathyroid hormone treatment on new bone formation during distraction osteogenesis in the rat mandible. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Jul;114(1):e36-42. doi: 10.1016/j.oooo.2011.08.009. Epub 2012 Feb 25.
Anabtawi M, Tweedale H, Mahmood H The role, efficacy and outcome measures for teriparatide use in the management of medication-related osteonecrosis of the jaw. Int J Oral Maxillofac Surg. 2021 Apr;50(4):501-510. doi: 10.1016/j.ijom.2020.07.021. Epub 2020 Aug 14.
Boabaid F, Berry JE, Koh AJ, Somerman MJ, McCcauley LK The role of parathyroid hormone-related protein in the regulation of osteoclastogenesis by cementoblasts. J Periodontol. 2004 Sep;75(9):1247-54. doi: 10.1902/jop.2004.75.9.1247.
Camili Y, Malkoc S, Taslidere A, Ileri Z, Guler OC Effects of teriparatide on bone formation in rats with experimentally induced premaxillary expansion. Dental Press J Orthod. 2022 Jul 4;27(3):e2220370. doi: 10.1590/2177-6709.27.3.e2220370.oar. eCollection 2022.
Chan HL, McCauley LK Parathyroid hormone applications in the craniofacial skeleton. J Dent Res. 2013 Jan;92(1):18-25. doi: 10.1177/0022034512464779. Epub 2012 Oct 15.
Dam C, Jung UW, Park KM, Huh J, Park W Effect of teriparatide on early sinus graft healing in the ovariectomized rabbit. Clin Oral Implants Res. 2020 Mar;31(3):264-273. doi: 10.1111/clr.13565. Epub 2020 Jan 3.
Jung J, Shim GJ, Kim M, Yoon Y, Kim JE, Jue SS, Al-Nawas B, Kwon YD Effect and timing of parathyroid hormone analog administration for preventing medication-related osteonecrosis of the jaws in a murine model. J Craniomaxillofac Surg. 2021 Aug;49(8):719-725. doi: 10.1016/j.jcms.2021.02.023. Epub 2021 Feb 26.
Keskinruzgar A, Bozdag Z, Aras MH, Demir T, Yolcu U, Cetiner S Histopathological Effects of Teriparatide in Medication-Related Osteonecrosis of the Jaw: An Animal Study. J Oral Maxillofac Surg. 2016 Jan;74(1):68-78. doi: 10.1016/j.joms.2015.07.005. Epub 2015 Jul 14.
Koca CG, Kosehasanogullari M Evaluation of single-dose applied teriparatide effect on bone healing with histomorphometric and micro-ct analysis. J Craniomaxillofac Surg. 2021 Feb;49(2):98-103. doi: 10.1016/j.jcms.2020.12.004. Epub 2020 Dec 17.
Kuchler U, Luvizuto ER, Tangl S, Watzek G, Gruber R Short-term teriparatide delivery and osseointegration: a clinical feasibility study. J Dent Res. 2011 Aug;90(8):1001-6. doi: 10.1177/0022034511407920. Epub 2011 May 9.
Kuroshima S, Al-Salihi Z, Yamashita J Parathyroid hormone related to bone regeneration in grafted and nongrafted tooth extraction sockets in rats. Implant Dent. 2013 Feb;22(1):71-6. doi: 10.1097/ID.0b013e318278f94d.
Li Y, Chen XY, Tang ZL, Tan JQ, Wang DX, Dong Q Differences in accelerated tooth movement promoted by recombinant human parathyroid hormone after mandibular ramus osteotomy. Am J Orthod Dentofacial Orthop. 2019 May;155(5):670-680. doi: 10.1016/j.ajodo.2018.06.014.
Li Y, Qian Y, Qiao H, Pan W, Xie L, Li Y Abaloparatide outperforms teriparatide in protecting against alveolar bone loss in experimental periodontitis. J Periodontol. 2023 Feb;94(2):244-255. doi: 10.1002/JPER.22-0211. Epub 2022 Nov 8.
Liu J, Cao Z, Li C Intermittent PTH administration: a novel therapy method for periodontitis-associated alveolar bone loss. Med Hypotheses. 2009 Mar;72(3):294-6. doi: 10.1016/j.mehy.2008.10.015. Epub 2008 Nov 30.
Miller SC, Hunziker J, Mecham M, Wronski TJ Intermittent parathyroid hormone administration stimulates bone formation in the mandibles of aged ovariectomized rats. J Dent Res. 1997 Aug;76(8):1471-6. doi: 10.1177/00220345970760080901.
Otawa M, Tanoue R, Kido H, Sawa Y, Yamashita J Intermittent administration of parathyroid hormone ameliorates periapical lesions in mice. J Endod. 2015 May;41(5):646-51. doi: 10.1016/j.joen.2014.12.008. Epub 2015 Jan 30.
Tang ZL, Zhang WJ, Wang DX, Chen JM, Ma H, Wu DR An experimental study addressing the promotion of mandibular defect repair through the intermittent subcutaneous injection of parathyroid hormone. J Oral Maxillofac Surg. 2014 Feb;72(2):419-30. doi: 10.1016/j.joms.2013.07.037. Epub 2013 Sep 24.
Tsunori K Effects of parathyroid hormone dosage and schedule on bone regeneration. J Oral Sci. 2015 Jun;57(2):131-6. doi: 10.2334/josnusd.57.131.
Valderrama P, Jung RE, Thoma DS, Jones AA, Cochran DL Evaluation of parathyroid hormone bound to a synthetic matrix for guided bone regeneration around dental implants: a histomorphometric study in dogs. J Periodontol. 2010 May;81(5):737-47. doi: 10.1902/jop.2010.090562.
Wolf M, Lossdorfer S, Abuduwali N, Meyer R, Kebir S, Gotz W, Jager A Effect of intermittent PTH(1-34) on human periodontal ligament cells transplanted into immunocompromised mice. Tissue Eng Part A. 2012 Sep;18(17-18):1849-56. doi: 10.1089/ten.TEA.2011.0626. Epub 2012 May 21.
Yoshida W, Matsugami D, Murakami T, Bizenjima T, Imamura K, Seshima F, Saito A Combined effects of systemic parathyroid hormone (1-34) and locally delivered neutral self-assembling peptide hydrogel in the treatment of periodontal defects: An experimental in vivo investigation. J Clin Periodontol. 2019 Oct;46(10):1030-1040. doi: 10.1111/jcpe.13170.
Zandi M, Dehghan A, Amini P, Doulati S, Rezaeian L Evaluation of the effect of teriparatide therapy on mandibular fracture healing in rats with medication-related osteonecrosis of the jaw. Clin Oral Investig. 2019 Nov;23(11):3987-3993. doi: 10.1007/s00784-019-02830-2. Epub 2019 Feb 4.
Zandi M, Dehghan A, Bigonah N, Doulati S, Mohammad Gholi Mezerji N Histological assessment of the effects of teriparatide therapy on mandibular fracture healing: A preclinical study. J Craniomaxillofac Surg. 2020 Mar;48(3):211-216. doi: 10.1016/j.jcms.2020.01.006. Epub 2020 Jan 21.
Zandi M, Dehghan A, Mohammadi-Mofrad A, Amini P, Vahdatinia F Short-term perioperative teriparatide therapy for the prevention of medication-related osteonecrosis of the jaw: A randomized, controlled preclinical study in rats. J Craniomaxillofac Surg. 2017 Feb;45(2):275-280. doi: 10.1016/j.jcms.2016.12.010. Epub 2016 Dec 19.
Zandi M, Dehghan A, Zandipoor N, Amini P, Doulati S Effect of different doses and durations of teriparatide therapy on resolution of medication-related osteonecrosis of the jaw: A randomized, controlled preclinical study in rats. J Craniomaxillofac Surg. 2018 Mar;46(3):466-472. doi: 10.1016/j.jcms.2017.12.027. Epub 2017 Dec 30.
Zeng X, He H, Zhang L, Wu Y, Wang Y, Gong P A potential therapeutic approach to overload-induced bone loss around implant: parathyroid hormone (PTH). Med Hypotheses. 2011 Nov;77(5):701-4. doi: 10.1016/j.mehy.2011.06.016. Epub 2011 Sep 9.
Zhang C, Li T, Zhou C, Huang L, Li Y, Wang H, Duan P, Zou S, Mei L Parathyroid hormone increases alveolar bone homoeostasis during orthodontic tooth movement in rats with periodontitis via crosstalk between STAT3 and beta-catenin. Int J Oral Sci. 2020 Dec 30;12(1):38. doi: 10.1038/s41368-020-00104-2.
Bone Microarchitecture and Implant Stabilization in Atrophic Jaws Reconstructed With Bone Grafts Treated With Teriparatide
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.